HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study.

AbstractOBJECTIVE:
This study aimed to describe the contemporary aetiology, clinical characteristics and mortality and its predictors in heart failure (HF) in Tanzania.
METHODS:
Design; Prospective observational study. Setting; Cardiovascular Center of the Muhimbili National Hospital in Dar es Salaam, Tanzania. Patients ≥18 years of age with HF defined by the Framingham criteria.
MAIN OUTCOME MEASURE:
All-cause mortality.
RESULTS:
Among 427 included patients, 217 (51%) were females and the mean (SD) age was 55 (17) years. HF aetiologies included hypertension (45%), cardiomyopathy (28%), rheumatic heart disease (RHD) (12%) and ischaemic heart disease (9%). Concurrent atrial fibrillation (AF), clinically significant anaemia, diabetes, tuberculosis and HIV were found in 16%, 12%, 12%, 3% and 2%, respectively, while warfarin was used in 3% of the patients. The mortality rate, 22.4 per 100 person-years over a median follow-up of 7 months, was independently associated with AF, HR 3.4 (95% CI 1.6 to 7.0); in-patient 3.2 (1.5 to 6.8); anaemia 2.3 (1.2 to 4.5); pulmonary hypertension 2.1 (1.1 to 4.2) creatinine clearance 0.98 (0.97 to 1.00) and lack of education 2.3 (1.3 to 4.2).
CONCLUSIONS:
In HF in Tanzania, patients are younger than in the developed world, but aetiologies are becoming more similar, with hypertension becoming more and RHD less important. Predictors of mortality possible to intervene against are anaemia, AF and lack of education.
AuthorsAbel Makubi, Camilla Hage, Johnson Lwakatare, Peter Kisenge, Julie Makani, Lars Rydén, Lars H Lund
JournalHeart (British Cardiac Society) (Heart) Vol. 100 Issue 16 Pg. 1235-41 (Aug 2014) ISSN: 1468-201X [Electronic] England
PMID24743164 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Chemical References
  • Warfarin
Topics
  • Anemia (epidemiology)
  • Atrial Fibrillation (drug therapy, epidemiology)
  • Comorbidity
  • Diabetes Mellitus (epidemiology)
  • Educational Status
  • Female
  • HIV Infections (epidemiology)
  • Heart Failure (diagnosis, etiology, mortality, physiopathology)
  • Humans
  • Kidney Function Tests
  • Male
  • Middle Aged
  • Mortality
  • Prognosis
  • Prospective Studies
  • Tanzania (epidemiology)
  • Tertiary Care Centers
  • Tuberculosis (epidemiology)
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: